OPPENHEIRER reaffirm Dexcom Buric Buric Classification Classes HHS devices that can be wearable devices

Dexcom, Inc. (Nasdaq:DxcmThe ranking between The best basic shares for purchase according to hedge boxes. Obenheimer has reaffirmed its target classification of $ 95 for prices and output on Dexcom, Inc. (NASDAQ: DXCM) on June 24 in response to the observations made by the Minister of Health and Humanitarian Services RFK JR. Regarding an important campaign on lying devices.

On June 24, the House Energy and Commerce Health Committee, Secretary Kennedy announced that HHS will soon start “one of the largest advertising campaigns in HHS history” to strengthen wearable devices between Americans, while emphasizing the advantages of glucose monitors.

The possibility of a major government marketing campaign encouraging companies that provide continuous glucose monitoring (CGM), as Obenheimer, who also noticed that the minister’s observations may indicate interest in the future coverage of CGMS that are not printed.

Obenheimer also pointed to the recent developments in CGM coverage of type 2 diabetes 2, pointing to a tight experiment with evidence that is expected to end in late 2025 or early 2026 for medical care patients with type 2 diabetes.

Dexcom, Inc. (NASDAQ: DXCM) is a medical devices company that manufactures continuous glucose monitoring systems (CGM) to allow controlling health management in actual time.

While we acknowledge the DXCM capabilities as an investment, we believe that some artificial intelligence shares provide greater potential in the upward trend and carry less negative risks. If you are looking for a stock of artificial intelligence with less than very apprecia The best inventory of artificial intelligence in the short term.

Read more: 10 Best Magic Formulas stocks for 2025 and 10 best pension shares to buy according to hedge boxes

Detection: Nothing.